carnosine has been researched along with Idiopathic Parkinson Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Hiep, NT; Hong, S; Hwang, BY; Kim, DW; Kwon, J; Lee, D; Lee, HJ; Mar, W | 1 |
| Kawahara, M; Kobayashi, N; Kubota, M; Shimoda, M; Sugizaki, T; Tanaka, KI | 1 |
| Baker, LS; Brown, JM; Genter, MB; Seroogy, KB | 1 |
| Berezhnoy, DS; Fedorova, TN; Kulikova, OI; Lopachev, AV; Orlova, VS; Stvolinsky, SL | 1 |
| Bermúdez, ML; Genter, MB; Skelton, MR | 1 |
| Bermúdez, ML; Genter, MB; Seroogy, KB | 1 |
| Hipkiss, AR | 1 |
| Cacciatore, I; Cantalamessa, F; Cerasa, LS; Cornacchia, C; Di Stefano, A; Giorgioni, G; Iannitelli, A; Nasuti, C; Ricciutelli, M; Sozio, P | 1 |
| Bagyeva, G; Boldanova, N; Boldyrev, A; Dobrotvorskaya, I; Fedorova, T; Illarioshkin, S; Ivanova-Smolenskaya, I; Kozlova, E; Stepanova, M | 1 |
| Kuo, WW; Liu, WH; Tsai, SJ; Yin, MC | 1 |
| Boldyrev, A; Bryushkova, E; Mashkina, A; Vladychenskaya, E | 1 |
| Kang, JH; Kim, KS | 1 |
| Chen, Z; Hu, WW; Shen, Y | 1 |
| Agid, Y; Bonnet, AM; De Smet, Y; Grove, J; Saint-Hilaire, MH; Schechter, PJ; Tell, G | 1 |
2 review(s) available for carnosine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Aging risk factors and Parkinson's disease: contrasting roles of common dietary constituents.
Topics: Aging; Animals; Carnosine; Clinical Trials as Topic; Dietary Carbohydrates; Dietary Supplements; Double-Blind Method; Humans; Parkinson Disease; Pyruvaldehyde; Risk Factors; Treatment Outcome | 2014 |
[Carnosine and diseases of central nervous system].
Topics: Alzheimer Disease; Brain Diseases; Brain Ischemia; Carnosine; Central Nervous System Diseases; Humans; Parkinson Disease | 2007 |
1 trial(s) available for carnosine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Carnosine [corrected] increases efficiency of DOPA therapy of Parkinson's disease: a pilot study.
Topics: Adult; Aged; Carnosine; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Male; Middle Aged; Monoamine Oxidase; Oxidative Stress; Parkinson Disease; Pilot Projects; Protein Carbonylation; Superoxide Dismutase; Treatment Outcome | 2008 |
11 other study(ies) available for carnosine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects.
Topics: Animals; Cell Death; Disease Models, Animal; Glucose; Ischemia; Moraceae; Neuroprotective Agents; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Plant Bark; Plant Roots; Republic of Korea; Xanthones | 2016 |
Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.
Topics: Animals; Carnosine; Cell Death; Cell Line; Cytokines; Gene Expression Regulation; Humans; MAP Kinase Signaling System; Mice; Models, Biological; Oxidative Stress; Oxidopamine; Parkinson Disease; Reactive Oxygen Species | 2020 |
Intranasal Carnosine Mitigates α-Synuclein Pathology and Motor Dysfunction in the Thy1-aSyn Mouse Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Carnosine; Disease Models, Animal; Mice; Mice, Transgenic; Parkinson Disease | 2021 |
Neuroprotective effect of the carnosine - α-lipoic acid nanomicellar complex in a model of early-stage Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Brain; Carnosine; Dopamine; Homovanillic Acid; Male; Micelles; Nanoparticles; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Rats, Wistar; Serotonin; Thioctic Acid | 2018 |
Intranasal carnosine attenuates transcriptomic alterations and improves mitochondrial function in the Thy1-aSyn mouse model of Parkinson's disease.
Topics: Administration, Intranasal; alpha-Synuclein; Animals; Carnosine; Corpus Striatum; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Mitochondria; Parkinson Disease; Thy-1 Antigens; Transcriptome | 2018 |
Evaluation of Carnosine Intervention in the Thy1-aSyn Mouse Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Carnosine; Disease Models, Animal; Mice; Mice, Transgenic; Motor Activity; Parkinson Disease; Smell; Treatment Outcome | 2019 |
New L-dopa codrugs as potential antiparkinson agents.
Topics: Administration, Oral; Animals; Antioxidants; Antiparkinson Agents; Caffeic Acids; Carnosine; Corpus Striatum; Dopamine; Glutathione Peroxidase; Levodopa; Parkinson Disease; Rats; Superoxide Dismutase | 2008 |
Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Carnosine; Corpus Striatum; Glutathione; Humans; Interleukin-6; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease; Tumor Necrosis Factor-alpha | 2010 |
Why is homocysteine toxic for the nervous and immune systems?
Topics: Animals; Brain Ischemia; Carnosine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Neuroimmunomodulation; Neuroprotective Agents; Parkinson Disease; Pregnancy; Rats; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate | 2013 |
Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Topics: alpha-Synuclein; Amino Acid Substitution; Anserine; Antioxidants; Antiparkinson Agents; Biopolymers; Carnosine; Chelating Agents; Codon; Copper; Edetic Acid; Free Radical Scavengers; Humans; Hydrogen Peroxide; Hydroxyl Radical; Isopropyl Thiogalactoside; Lewy Bodies; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Phenylmethylsulfonyl Fluoride; Point Mutation; Resins, Synthetic; Spin Labels; Superoxide Dismutase; Superoxide Dismutase-1; Synucleins; Tyrosine | 2003 |
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
Topics: Adult; Aged; Carnosine; Dipeptides; Female; Friedreich Ataxia; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease | 1987 |